IceCure Medical has announced that the John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California, treated its first breast cancer patient using the IceSense3 cryoablation system in a pilot study evaluating ...
As cholesterol is metabolized, a potent stimulant of breast cancer is created -- one that fuels estrogen-receptor positive breast cancers, U.S. researchers say. Senior author Dr. Philip Shaul, professor and vice chair for research in ...
Tags: cholesterol, breast cancer, hormone, endocrine
US-based biotechnology firm Ignyta has entered into a license agreement with Nerviano Medical Sciences (Nerviano), under which Ignyta will get exclusive global development and marketing rights of tyrosine kinase inhibitors RXDX-101 and ...
Tags: Ignyta, Tyrosine Kinase Inhibitors
Transgenomic, a global biotechnology company, and US-based PerkinElmer have entered into a collaboration agreement for marketing and distributing Transgenomic’s line of molecular diagnostic oncology products in territories outside the ...
Advanced Medical Isotope (AMIC), a developer of medical isotopes, has filed 510(k) pre-market notification to the US Food and Drug Administration (FDA) approval for its Yttrium-90 RadioGel brachytherapy cancer product. In accordance to ...
Janssen-Cilag (Janssen), a subsidiary of Johnson & Johnson pharmaceutical firm, has submitted marketing authorization application (MAA) to the European Medicines Agency (EMA) for the approval of once daily oral drug ibrutinib for the ...
Tags: Blood Cancer Medicine, Medicine
Calithera Biosciences has completed a $35m series D financing led by Adage Capital Partners, LP. Joining Adage as new investors in this financing are the Longwood Fund and two other institutional investor groups. The transaction also ...
Stemline Therapeutics, a clinical stage biopharmaceutical company, and The Leukemia & Lymphoma Society (LLS), a voluntary health organization, have announced their collaboration to accelerate the development of SL-401 for the treatment of ...
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
KEW Group, the oncology personalized medicine management and analytics company, has launched CancerPlex assay, a comprehensive gene testing panel that can be used to examine the genetic profile of many common cancers. Developed and ...
Tags: Genomic Testing, Medicine
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
US-based MetaStat has announced that a study of 481 women with breast cancer has confirmed that the MetaSite Score (a count of the number of TMEM structures) was found to be associated with a statistically significant increase in the risk ...
Tags: MetaStat, Breast Cancer
The University of Michigan’s Department of Pathology MLabs has announced the commercial availability of Mi-prostate score (MiPS) test for men, a new urine test that measures minute fragments of RNA in prostate cancer. The test ...
Tags: Prostate Cancer, Medicine
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
As the depletion of Earth’s ozone layer continues, there is an increase in direct exposure to ultraviolet (UV) rays and as a result of research studies as well as skin cancer awareness organizations, the demand for sun protective ...
Tags: UV Clothing, Growing Awareness